The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Metabolic crosstalk between fatty pancreas and fatty liver: effects on local inflammation and insulin secretion
Open accessAbstract
Aims/hypothesis Obesity-linked ectopic fat accumulation is associated with the development of type 2 diabetes. Whether pancreatic and liver steatosis impairs insulin secretion is controversial. We examined the crosstalk of human pancreatic fat cells with islets and the role of diabetogenic factors, i.e. palmitate and fetuin-A, a hepatokine released from fatty liver. Methods Human pancreatic resections were immunohistochemically stained for insulin, glucagon, somatostatin and the macrophage/monocyte marker CD68. Pancreatic adipocytes were identified by Oil Red O and adiponectin staining. Primary pancreatic pre-adipocytes and differentiated adipocytes were co-cultured with human islets isolated from organ donors and the metabolic crosstalk between fatty liver and fatty pancreas was mimicked by the addition of palmitate and fetuin-A. Insulin secretion was evaluated by ELISA and RIA. Cytokine expression and secretion were assessed by RT-PCR and multiplex assay, respectively. Subcellular distribution of proteins was examined by confocal microscopy and protein phosphorylation by western blotting. Results In human pancreatic parenchyma, highly differentiated adipocytes were detected in the proximity of islets with normal architecture and hormone distribution. Infiltration of adipocytes was associated with an increased number of CD68-positive cells within islets. In isolated primary pancreatic pre-adipocytes and differentiated adipocytes, palmitate and fetuin-A induced IL6, CXCL8 and CCL2 mRNA expression. Cytokine production was toll-like receptor 4 (TLR4)-dependent and further accentuated in pre-adipocytes when co-cultured with islets. In islets, IL6 and CXCL8 mRNA levels were also increased by fetuin-A and palmitate. Only in macrophages within the isolated islets, palmitate and fetuin-A stimulated the production of the cytotoxic cytokine IL-1β. Palmitate, but not fetuin-A, exerted pro-apoptotic effects in islet cells. Instead, fetuin-A impaired glucose-induced insulin secretion in a TLR4-independent, but c-Jun N-terminal kinase- and Ca 2+-dependent, manner. Conclusions/interpretation These results provide the first evidence that fetuin-A-mediated metabolic crosstalk of fatty liver with islets may contribute to obesity-linked glucose blindness of beta cells, while fatty pancreas may exacerbate local inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fetulin-A has been shown to impair β-cell sensing by reducing glucose-stimulated insulin secretion115.”
From Exerkines in health, resilience and disease (2022) · cites this paper as [115]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62154-6 · Cited by 1,743
Islet cell failure in type 2 diabetes
Prentki, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29103 · Cited by 1,690
Pancreatic β Cell Dedifferentiation as a Mechanism of Diabetic β Cell Failure
Talchai, C., Xuan, S., Lin, H. V., Sussel, L., & Accili, D. (2012) · Cell · doi:10.1016/j.cell.2012.07.029 · Cited by 1,415
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller‐Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15318 · Cited by 1,141
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller‐Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92172 · Cited by 1,113
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller‐Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215318 · Cited by 1,006
Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance
Pal, D., Dasgupta, S., Kundu, R., Maitra, S., Das, G., Mukhopadhyay, S., Ray, S., Majumdar, S. S., & Bhattacharya, S. (2012) · Nature Medicine · doi:10.1038/nm.2851 · Cited by 922 · cited 1×
“agreement with our previous studies using perivascular fat cells and the proposed proinflammatory effect of fetuin-A and palmitate via TLR4 stimulation [29, 30].”
Increased Number of Islet-Associated Macrophages in Type 2 Diabetes
Ehses, J. A., Perren, A. A., Eppler, E., Ribaux, P., Pospisilik, J. A., Maor-Cahn, R., Guéripel, X., Ellingsgaard, H., Schneider, M. K. J., Biollaz, G., et al. (2007) · Diabetes · doi:10.2337/db06-1650 · Cited by 804
Cited by
Sorted by citations
Exerkines in health, resilience and disease
Chow, L. S., Gerszten, R. E., Taylor, J. M., Pedersen, B. K., van Praag, H., Trappe, S., Febbraio, M. A., Galis, Z. S., Gao, Y., Haus, J. M., et al. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00641-2 · Cited by 927
Lipid droplet biogenesis and functions in health and disease
Zadoorian, A., Du, X., & Yang, H. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00845-0 · Cited by 617
The Liver as an Endocrine Organ—Linking NAFLD and Insulin Resistance
Watt, M. J., Miotto, P. M., De Nardo, W., & Montgomery, M. K. (2019) · Endocrine Reviews · doi:10.1210/er.2019-00034 · Cited by 615
Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes
Wagner, R., Heni, M., Tabák, A. G., Machann, J., Schick, F., Randrianarisoa, E., Hrabě de Angelis, M., Birkenfeld, A. L., Stefan, N., Peter, A., et al. (2021) · Nature Medicine · doi:10.1038/s41591-020-1116-9 · Cited by 415
Self-citationThe role of hepatokines in NAFLD
Stefan, N., Schick, F., Birkenfeld, A. L., Häring, H., & White, M. F. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.01.006 · Cited by 288
Self-citationInter-organ crosstalk during development and progression of type 2 diabetes mellitus
Xourafa, G., Korbmacher, M., & Roden, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00898-1 · Cited by 274
White adipocyte dysfunction and obesity-associated pathologies in humans
Hagberg, C. E., & Spalding, K. L. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00680-1 · Cited by 236
Metabolic implications of pancreatic fat accumulation
Wagner, R. J., Eckstein, S. S., Yamazaki, H., Gerst, F., Machann, J., Jaghutriz, B. A., Schürmann, A., Solimena, M., Singer, S., Königsrainer, A., et al. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00573-3 · Cited by 195
Self-citationFood Polyphenols and Type II Diabetes Mellitus: Pharmacology and Mechanisms
Naz, R., Saqib, F., Awadallah, S. M., Wahid, M., Latif, M. F., Iqbal, I., & Mubarak, M. S. (2023) · Molecules · doi:10.3390/molecules28103996 · Cited by 178
Kahleová, H., Tura, A., Hill, M., Holubkov, R., & Barnard, N. D. (2018) · Nutrients · doi:10.3390/nu10020189 · Cited by 169
The structure, biosynthesis, and biological roles of fetuin-A: A review
Abebe, E. C., Muche, Z. T., Mariam, A. B. T., Ayele, T. M., Agidew, M. M., Azezew, M. T., Zewde, E. A., Dejenie, T. A., & Mengstie, M. A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.945287 · Cited by 151
Pathophysiology of type 2 diabetes and the impact of altered metabolic interorgan crosstalk
Sanches, J. M., Zhao, L. N., Salehi, A. A., Wollheim, C. B., & Kaldis, P. (2021) · FEBS Journal · doi:10.1111/febs.16306 · Cited by 136
Fatty change of the pancreas: the Pandora's box of pancreatology
Petrov, M. S. (2023) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(23)00064-x · Cited by 111
Organ-organ communication: The liver's perspective
Wang, F., So, K., Xiao, J., & Wang, H. (2021) · Theranostics · doi:10.7150/thno.55795 · Cited by 107
What role do fat cells play in pancreatic tissue?
Gerst, F., Wagner, R. J., Oquendo, M. B., Siegel-Axel, D. I., Fritsche, A., Heni, M., Staiger, H., Häring, H., & Ullrich, S. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.05.001 · Cited by 94
Self-citationPorcine models for studying complications and organ crosstalk in diabetes mellitus
Renner, S., Blutke, A., Clauß, S., Deeg, C. A., Kemter, E., Merkus, D., Wanke, R., & Wolf, E. (2020) · Cell and Tissue Research · doi:10.1007/s00441-019-03158-9 · Cited by 94
Wang, J., He, Y., Yu, D., Jin, L., Gong, X., & Zhang, B. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110965 · Cited by 83
Filippatos, T. D., Alexakis, K., Mavrikaki, V., & Mikhailidis, D. P. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-06824-7 · Cited by 85
Wagner, R. J., Jaghutriz, B. A., Gerst, F., Oquendo, M. B., Machann, J., Schick, F., Loeffler, M. W., Nadalin, S., Fend, F., Königsrainer, A., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa435 · Cited by 76
Self-citationImpact of Fetuin-A (AHSG) on Tumor Progression and Type 2 Diabetes
Ochieng, J., Nangami, G. N., Sakwe, A. M., Moye, C., Alvarez, J., Whalen, D. S., Thomas, P. L., & Lammers, P. E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082211 · Cited by 66
Fat Distribution Patterns and Future Type 2 Diabetes
Yamazaki, H., Tauchi, S., Machann, J., Haueise, T., Yamamoto, Y., Dohke, M., Hanawa, N., Kodama, Y., Katanuma, A., Stefan, N., et al. (2022) · Diabetes · doi:10.2337/db22-0315 · Cited by 66
Self-citationYamazaki, H., Tauchi, S., Wang, J., Dohke, M., Hanawa, N., Kodama, Y., Katanuma, A., Saisho, Y., Kamitani, T., Fukuhara, S., et al. (2020) · Journal of Gastroenterology · doi:10.1007/s00535-020-01683-x · Cited by 60
β- cell dynamics in type 2 diabetes and in dietary and exercise interventions
Lv, C.-A., Sun, Y., Zhang, Z. Y., Aboelela, Z., Qiu, X., & Meng, Z. (2022) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjac046 · Cited by 57
The Expression of Aldolase B in Islets Is Negatively Associated With Insulin Secretion in Humans
Gerst, F., Jaghutriz, B. A., Staiger, H., Schulte, A. M., Lorza‐Gil, E., Kaiser, G., Panse, M., Haug, S., Heni, M., Schütz, M., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00791 · Cited by 55
Self-citationRole of exercise-induced hepatokines in metabolic disorders
Ennequin, G., Sirvent, P., & Whitham, M. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00433.2018 · Cited by 54
Prediabetes remission to reduce the global burden of type 2 diabetes
Sandforth, L., Kullmann, S., Sandforth, A., Fritsche, A., von Schwartzenberg, R. J., Stefan, N., & Birkenfeld, A. L. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.01.004 · Cited by 55
Self-citationEffects of fetuin-A with diverse functions and multiple mechanisms on human health
İçer, M. A., & Yıldıran, H. (2020) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2020.11.004 · Cited by 51
Gao, D., Jiao, J., Wang, Z., Huang, X., Ni, X., Fang, S., Zhou, Q., Zhu, X., Sun, L., Yang, Z. R., et al. (2022) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2022.04.002 · Cited by 52
TLR4 triggered complex inflammation in human pancreatic islets
He, W., Rebello, O. D., Savino, R., Terracciano, R., Schuster, C., Guardiola, B., & Maedler, K. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.09.030 · Cited by 48
Fetuin-A levels are increased in the adipose tissue of diabetic obese humans but not in circulation
Khadir, A., Kavalakatt, S., Madhu, D., Hammad, M. M., Devarajan, S., Tuomilehto, J., & Tiss, A. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0919-x · Cited by 49
The chemokine system and its role in obesity
Xue, W., Fan, Z., Li, L., Lü, J., Zhai, Y., & Zhao, J. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27293 · Cited by 48
Obesity linking to hepatocellular carcinoma: A global view
Gan, L., Liu, Z., & Sun, C. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.12.006 · Cited by 46
Pancreatic steatosis and metabolic pancreatic disease: a new entity?
Caldart, F., de Pretis, N., Luchini, C., Ciccocioppo, R., & Frulloni, L. (2023) · Internal and Emergency Medicine · doi:10.1007/s11739-023-03364-y · Cited by 45
Adeyanju, O. A., Badejogbin, O. C., Areola, E. D., Olaniyi, K. S., Dibia, C., Soetan, O. A., Oniyide, A. A., Michael, O. S., Olatunji, L. A., & Soladoye, A. O. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110994 · Cited by 44
Al-Mrabeh, A. H. (2021) · Biomedicines · doi:10.3390/biomedicines9020226 · Cited by 43
He, W., Yuan, T., Choezom, D., Hunkler, H. J., Annamalai, K., Lupše, B., & Maedler, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-20909-w · Cited by 41
Pancreatic adipocytes mediate hypersecretion of insulin in diabetes-susceptible mice
Quiclet, C., Dittberner, N., Gässler, A., Stadion, M., Gerst, F., Helms, A., Baumeier, C., Schulz, T. J., & Schürmann, A. (2019) · Metabolism · doi:10.1016/j.metabol.2019.05.005 · Cited by 40
Self-citationQu, H., Qiu, Y., Wang, Y., Liao, Y., Zheng, Y., & Zheng, H. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.02.003 · Cited by 39
Chang, M. (2022) · Biomedicines · doi:10.3390/biomedicines10030692 · Cited by 38
Galectin-12 in Cellular Differentiation, Apoptosis and Polarization
Wan, L., Yang, R., & Liu, F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010176 · Cited by 35
Horii, T., Fujita, Y., Ishibashi, C., Fukui, K., Eguchi, H., Kozawa, J., & Shimomura, I. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001508 · Cited by 34
Keeping It Local in Metabolic Disease: Adipose Tissue Paracrine Signaling and Insulin Resistance
KAHN, D. E., & Bergman, B. C. (2022) · Diabetes · doi:10.2337/dbi21-0020 · Cited by 34
Fatty Pancreas: Linking Pancreas Pathophysiology to Nonalcoholic Fatty Liver Disease
Rugivarodom, M., Geeratragool, T., Pausawasdi, N., & Charatcharoenwitthaya, P. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00085 · Cited by 36
López-Bermudo, L., Luque‐Sierra, A., Maya‐Miles, D., Gallego‐Durán, R., Ampuero, J., Romero‐Gómez, M., Berná, G., & Martı́n, F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.892672 · Cited by 34
Vujasinović, M., Demir, İ. E., Marchegiani, G., Hegyi, P. J., Archibugi, L., Valente, R., Capurso, G., Witt, H., Bonovas, S., Piovani, D., et al. (2026) · United European Gastroenterology Journal · doi:10.1002/ueg2.70185 · Cited by 31
Self-citationThe hepatokine fetuin-A disrupts functional maturation of pancreatic beta cells
Gerst, F., Kemter, E., Lorza‐Gil, E., Kaiser, G., Fritz, A.-K., Nano, R., Piemonti, L., Gauder, M., Dahl, A., Nadalin, S., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05435-1 · Cited by 31
Self-citationFetuin-A and risk of diabetes-related vascular complications: a prospective study
Birukov, A., Polemiti, E., Jäger, S., Stefan, N., & Schulze, M. B. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01439-8 · Cited by 31
Self-citationAizenshtadt, A., Wang, C., Abadpour, S., Menezes, P. D., Wilhelmsen, I., Dalmao‐Fernández, A., Stokowiec, J., Golovin, A., Johnsen, M., Combriat, T. M. D., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303785 · Cited by 35
Islet Inflammation and β Cell Dysfunction in Type 2 Diabetes
Cuenco, J., & Dalmas, É. (2022) · Handbook of experimental pharmacology · doi:10.1007/164_2021_571 · Cited by 30
Sujana, C., Huth, C., Zierer, A., Meesters, S., Sudduth-Klinger, J., Köenig, W., Herder, C., Peters, A., & Thorand, B. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-1053 · Cited by 30
Chen, Y., Zhang, P., Lv, S., Su, X., Du, Y., Xu, C., & Jin, Z. (2022) · Endoscopic Ultrasound · doi:10.4103/eus-d-21-00167 · Cited by 29
Immune regulation of islet homeostasis and adaptation
Guo, J., & Fu, W. (2020) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjaa009 · Cited by 29
Mukhuty, A., Fouzder, C., & Kundu, R. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111314 · Cited by 28
Role of the Gut Microbiome in Beta Cell and Adipose Tissue Crosstalk: A Review
Martínez‐Montoro, J. I., Damas-Fuentes, M., Fernández‐García, J. C., & Tinahones, F. J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.869951 · Cited by 28
Chanclón, B., Wu, Y., Vujičić, M., Bauzá-Thorbrügge, M., Banke, E., Micallef, P., Kanerva, J., Wilder, B., Rorsman, P., & Asterholm, I. W. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-00657-6 · Cited by 27
Improvement of Pancreatic Steatosis and Indices of Insulin Resistance After Metabolic Surgery
Salman, A., Salman, M. A., Said, M., Sherbiny, M. E., Elkassar, H., Hassan, M. B., Marwan, A., Morad, M. A., Ashoush, O. A., Labib, S., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.894465 · Cited by 27
Wagner, R. J., Heni, M., Kantartzis, K., Sandforth, A., Machann, J., Schick, F., Peter, A., Fritsche, L., Szendrödi, J., Pfeiffer, A. F. H., et al. (2022) · Diabetes · doi:10.2337/db22-0441 · Cited by 25
Self-citationFetuin‐A excess expression amplifies lipid induced apoptosis and β‐cell damage
Mukhuty, A., Fouzder, C., & Kundu, R. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30499 · Cited by 23
Askarpour, M., Djafarian, K., Ghaedi, E., Sadeghi, O., Sheikhi, A., & Shab‐Bidar, S. (2020) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.12.005 · Cited by 22
Metabolomic Characteristics of Fatty Pancreas
Jaghutriz, B. A., Wagner, R. J., Heni, M., Lehmann, R., Machann, J., Stefan, N., Häring, H., & Fritsche, A. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0896-8671 · Cited by 21
Self-citationTremmel, D. M., Feeney, A. K., Mitchell, S. A., Chlebeck, P. J., Raglin, S. A., Fernandez, L. A., Odorico, J. S., & Sackett, S. D. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15698 · Cited by 20
Mukhuty, A., Fouzder, C., & Kundu, R. (2021) · Journal of Cell Science · doi:10.1242/jcs.258507 · Cited by 20
Chen, Y., Li, X., Su, L., Hu, Q., Li, W., He, J., & Zhao, L. (2022) · Nutrients · doi:10.3390/nu14091835 · Cited by 20
Metabolic-Associated Fatty Liver Disease and Insulin Resistance: A Review of Complex Interlinks
Barber, T. M., Kabisch, S., Pfeiffer, A. F. H., & Weickert, M. O. (2023) · Metabolites · doi:10.3390/metabo13060757 · Cited by 22
Li, N., Zhang, Y., Li, H., Han, L., Yan, X.-M., Li, H., Du, W., Zhang, J.-S., & Yu, Q. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206757 · Cited by 21
Effects of fullerene C60 supplementation on gut microbiota and glucose and lipid homeostasis in rats
Đurašević, S., Nikolić, G., Todorović, A., Drakulić, D., Pejić, S., Martinović, V., Mitić-Ćulafić, D., Milić, D. R., Kop, T. J., Jasnic, N. I., et al. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111302 · Cited by 20
Nowotny, B., KAHL, S., Klüppelholz, B., Hoffmann, B. H., Giani, G., Livingstone, R. S., Nowotny, P., Stamm, V., Herder, C., Tura, A., et al. (2017) · Metabolism · doi:10.1016/j.metabol.2017.12.005 · Cited by 19
Intrapancreatic adipocytes and beta cell dedifferentiation in human type 2 diabetes
Zhang, N., Sun, Q., Zhang, J., Zhang, R., Liu, S., Zhao, X., Ma, J., & Li, X. (2025) · Diabetologia · doi:10.1007/s00125-025-06392-9 · Cited by 18
Liang, Y.-C., Jia, M.-J., Li, L., Liu, D., Chu, S.-F., & Li, H.-L. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1358311 · Cited by 18
Hung, T.-C., Zhao, N., Huang, C., Liu, S., Liu, T., Huang, W., Xu, X., Ji, Z., & Yang, S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111408 · Cited by 18
Oquendo, M. B., Siegel-Axel, D. I., Gerst, F., Lorza‐Gil, E., Moller, A., Wagner, R. J., Machann, J., Fend, F., Königsrainer, A., Heni, M., et al. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00595.2020 · Cited by 18
Self-citationEffects of Sodium-Glucose Co-Transporter-2 Inhibitors on Pancreatic β-Cell Mass and Function
Nakamura, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095104 · Cited by 18
Extrahepatic factors in hepatic immune regulation
Zhang, S., Lu, S., & Li, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.941721 · Cited by 18
Ralston, J. C., Nguyen‐Tu, M., Lyons, C. L., Cooke, A. A., Murphy, A. M., Falvey, A., Finucane, O. M., McGillicuddy, F. C., Rutter, G. A., & Roche, H. M. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114520000859 · Cited by 17
Chen, Q., Jiang, F., Gao, X., Li, X., & Xia, P. (2023) · Liver International · doi:10.1111/liv.15654 · Cited by 16
Gezginci-Oktayoğlu, S., Sancar, S., Kaçar, A. K., & Bolkent, Ş. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30129 · Cited by 16
Detection of diabetes from whole-body MRI using deep learning
Dietz, B., Machann, J., Agrawal, V., Heni, M., Schwab, P., Dienes, J., Reichert, S., Birkenfeld, A. L., Häring, H., Schick, F., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.146999 · Cited by 16
Self-citationDoes Nonalcoholic Pancreatic Steatosis Always Correlate with Nonalcoholic Fatty Liver Disease?
Ulaşoğlu, C., Tekin, Z. N., Akan, K., & Yavuz, A. (2021) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s317340 · Cited by 15
Intrapancreatic fat deposition and nutritional treatment: the role of various dietary approaches
Pepa, G. D., Salamone, D., Testa, R., Bozzetto, L., & Costabile, G. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuad159 · Cited by 15
Chen, Y., Long, L., Jiang, Z., Zhang, L., Zhong, D., & Huang, X. (2019) · BMC Medical Imaging · doi:10.1186/s12880-019-0336-2 · Cited by 15
Alén, R., García‐Martinez, I., Cobo‐Vuilleumier, N., Fernández‐Millán, E., Gallardo-Villanueva, P., Ferreira, V., Izquierdo, M., Moro, M. Á., Lizasoaín, I., Nieto, N., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06445-z · Cited by 14
Exercise and inactivity as modifiers of β cell function and type 2 diabetes risk
Hall, L. G., Thyfault, J. P., & Johnson, J. D. (2023) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00472.2022 · Cited by 15
Omega-3 supplementation: Impact on low chronic inflammation associated with obesity
López-Millán, E., Gutierrez-Uribe, J. A., & Antunes‐Ricardo, M. (2024) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2024.104799 · Cited by 14
Lee-Ødegård, S., Ueland, T., Thorsby, P. M., Aukrust, P., Michelsen, A. E., Halvorsen, B. L., Drevon, C. A., & Birkeland, K. I. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01127-y · Cited by 13
Linder, T., Eppel, D., Kotzaeridi, G., Rosicky, I., Yerlikaya‐Schatten, G., Kiss, H., Weißhaupt, K., Henrich, W., Bozkurt, L., Tura, A., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109942 · Cited by 12
Aleman, J., Ravikumar, K., Wiegand, C., Schurdak, M. E., Vernetti, L. A., Gavlock, D. C., Reese, C. E., DeBiasio, R., LaRocca, G., Angarita, Y. D., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-07006-7 · Cited by 12
Severity of hyperechoic pancreas on ultrasonography as a risk factor for glycemic progression
Oh, J., Park, H. J., Lee, E. S., Park, S. B., Choi, B. I., & Ahn, S. (2021) · ULTRASONOGRAPHY · doi:10.14366/usg.20122 · Cited by 12
Kızılgül, M., Wilhelm, J. J., Beilman, G. J., Chinnakotla, S., Dunn, T. B., Pruett, T. L., Abdulla, M., Heller, D. A., Freeman, M. L., Schwarzenberg, S. J., et al. (2017) · Journal of Diabetes · doi:10.1111/1753-0407.12589 · Cited by 12
Immunomodulation through Nutrition Should Be a Key Trend in Type 2 Diabetes Treatment
Napiórkowska-Baran, K., Treichel, P., Czarnowska, M., Drozd, M., Koperska, K., Węglarz, A., Schmidt, O., Darwish, S., Szymczak, B., & Bartuzi, Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073769 · Cited by 11
Ahn, M. B., Kim, S.-K., Kim, S. H., Cho, W. K., Suh, J., Cho, K., Suh, B., & Jung, M. H. (2021) · Children · doi:10.3390/children8121155 · Cited by 11
Oquendo, M. B., Lorza‐Gil, E., Juarez-Lopez, D., Wagner, R. J., Birkenfeld, A. L., Ullrich, S., & Gerst, F. (2022) · Scientific Reports · doi:10.1038/s41598-022-18262-0 · Cited by 11
Self-citationCarvalho, V., Wang, Q., Xu, X., Liu, L., Jiang, W., Wang, X., Wang, J., Li, W., Chen, J., Li, T., et al. (2023) · The FASEB Journal · doi:10.1096/fj.202201879r · Cited by 11
Sezgın, O., Yaraş, S., Cindoruk, M., Kasap, E., Unal, H. U., Köksal, A. Ş., Yıldırım, A. E., Özşeker, B., Oruç, N., Soytürk, M., et al. (2024) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2024.23583 · Cited by 10
Effects of a Carbohydrate-Restricted Diet on β-Cell Response in Adults With Type 2 Diabetes
Gower, B. A., Goss, A. M., YURCHISHIN, M. L., Deemer, S. E., Sunil, B., & Garvey, W. T. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae670 · Cited by 10
Sandby, K., Krarup, T., Chabanova, E., Geiker, N. R. W., & Magkos, F. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae572 · Cited by 11
Lorza‐Gil, E., Strauß, O., Ziegler, E., Kansy, K., Katschke, M.-T., Rahimi, G., Neuscheler, D., Sandforth, L., Sandforth, A., Sancar, G., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.102067 · Cited by 9
Self-citationQiu, Z., & Shang, D. (2025) · Metabolism Open · doi:10.1016/j.metop.2025.100418 · Cited by 9
Laget, J., Djohan, Y. F., Jeanson, L., Muyor, K., Badia, É., Cristol, J., Coudray, C., Feillet‐Coudray, C., Vigor, C., Oger, C., et al. (2021) · Nutrients · doi:10.3390/nu13041134 · Cited by 9
Polycystic ovary syndrome and nonalcoholic fatty liver disease
Georgescu, C. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823045-9.00007-9 · Cited by 9
Iheagwam, F. N., Iheagwam, O. T., Ogunlana, O. O., & Chinedu, S. N. (2023) · Gene Expression · doi:10.14218/ge.2023.00053 · Cited by 8
Metadata
- Authors
- Gerst, F., Wagner, R., Kaiser, G., Panse, M., Heni, M., Machann, J., Bongers, M. N., Sartorius, T., Sipos, B., Fend, F., Thiel, C., Nadalin, S., Königsrainer, A., Stefan, N., Fritsche, A., Häring, H.-U., Ullrich, S., & Siegel-Axel, D.
- Affiliations
- Universitätsklinikum Tübingen (DE)
- Corresponding author
- Gerst, Felicia
- ORCID
- Venue
- Diabetologia
- Published
- 2017-08-08
- Volume
- 60
- Issue
- 11
- Pages
- 2240-2251
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2744324498
- Cited by
- 151
- References
- 53
- Citations by year
- 2026: 13 · 2025: 12 · 2024: 17 · 2023: 23 · 2022: 24 · 2021: 24 · 2020: 14 · 2019: 8 · 2018: 12 · 2017: 4
- FWCI
- 10.65
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Site cant be reached (submittedVersion)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Funders
- a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.) (01GI0925)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Keywords
- fatty pancreas, hepatic steatosis, metabolic crosstalk, insulin secretion, pancreatic islets, fetuin-A, palmitate, ectopic fat deposition, obesity, type 2 diabetes, insulitis, macrophages, TLR4, interleukin-6, interleukin-8, MCP-1, IL-1β, beta-cell apoptosis, c-Jun N-terminal kinase, glucose-stimulated insulin secretion, pancreatic resection
- MeSH terms
- Insulin Secretion, Animals, Cells, Cultured, Diabetes Mellitus, Type 2, Fatty Liver, Humans, Immunohistochemistry, Inflammation, Insulin, Palmitates, Pancreas, Blotting, Western, Interleukin-6, Interleukin-8, Chemokine CCL2, Insulin-Secreting Cells, Toll-Like Receptor 4, Mice, alpha-2-HS-Glycoprotein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
